Navigation Links
CCS Medical Appoints Michael A. Sicuro as Executive Vice President and Chief Financial Officer
Date:8/15/2011

DALLAS, Aug. 15, 2011 /PRNewswire/ -- CCS Medical (the Company), a leading provider of quality home medical supplies and services to patients with chronic conditions throughout the United States announced today the appointment of Michael A. Sicuro to the position of Executive Vice President and Chief Financial Officer.  Steve Saft, CCS Medical's previous CFO, will remain with the Company during a transition period.

President and Chief Executive Officer Dirk Allison stated: "Michael is a dynamic, results-oriented executive with a proven track record of helping to create value for shareholders.  He has demonstrated significant success in helping companies grow as well as working with companies to improve their operating performance.  I look forward to working with Michael."

Mr. Sicuro stated:  "I am very excited to have joined the CCS Medical team.  We have a strong business with excellent potential in one of the fastest growing chronic care sectors in health care.  I am confident that with the combination of Dirk's leadership and experience, the expertise of the management team and the support of our investors, especially Highland Capital Partners, L.P., a Dallas based investment management firm, that we can create significant value for our patients, partners and shareholders."

Executive Biography

Michael A. Sicuro has over 30 years of financial and operating leadership experience, including over 15 years as the Chief Financial Officer and/or operating executive in publicly-traded and privately held companies ranging from $50 million to over $4 billion in operating revenues in the healthcare, technology and financial services industries.  Most recently, Mr. Sicuro was the Executive Vice President and Chief Financial Officer for US Oncology, Inc., the largest cancer care services organization in the country with over $4 billion in revenues.

About CCS Medical

Established in 1994, CCS Medical is a leading provider of mail order medical supplies.  They assist patients that need diabetes test strips, insulin pumps, catheters, ostomy supplies, advanced wound care dressings and prescription medications.  CCS Medical's patient centered model specializes in a single source solution providing a convenient way for patients to receive supplies for their chronic conditions. They leverage strong manufacturer relationships to bring quality products at affordable prices. For more information on CCS Medical, please visit www.ccsmed.com.


'/>"/>
SOURCE CCS Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
(Date:3/23/2017)... 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or ... pharmaceutical company, is pleased to announce that its ... from the U.S. Food and Drug Administration (FDA) ... for tetrabenazine tablets in the 12.5 mg and ... a generic equivalent of the branded product Xenazine ...
(Date:3/23/2017)... , March 23, 2017   Casetabs , the ... native mobile app for the iPhone. With this new ... coordination and communication for physician offices, ambulatory surgery centers ... app offers iPhone users even faster, more reliable access ... it even easier to connect care teams so that ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and thank ... Every day, two kidneys filter about 120 to 150 quarts of blood. Put another ... regulating fluid levels and blood pressure, supporting bone health and promoting red blood cell ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... program owned and organized by HMP Communications Holdings, LLC, today announced that ... within its nationwide network of wound centers interested in becoming Certified Wound Specialist ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... ... ... After raising more than $1.135 million ($1,479,231 AUD) from nearly 20,000 backers ... crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle USA, LLC, ... excited to be operating on U.S. shores, where most of our initial crowdfunding backers ...
Breaking Medicine News(10 mins):